Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Understanding metabolic alterations after SARS-CoV-2 infection: insights from the patients’ oral microenvironmental metabolites

Fig. 3

Identification, screening and classification of metabolites between COVID-19 and control group. A The venn diagrams of the different features obtained with VIP > 1, p < 0.5 and FC ≥ 1.2 or ≤ 0.83 in different groups, 35 metabolites showed no significant differences in control and influenza, 10 metabolites showed significant differences in control and influenza. B Classification donut chart of 35 identified differential metabolites. C The heatmap of 35 metabolites dramatically changed in COVID-19 and control. D The box plots of cis-5,8,11,14,17-eicosapentaenoic acid, nicotinuric acid, guanosine 5′-monophosphate and proline based on the FC value greater than 100 in COVID-19. Green: Control subjects, blue: Influenza subjects, red: COVID-19 subjects. E. The box plots of hexanoic acid, heptanoic acid, 17α-hydroxyprogesterone and hexanoylcarnitine were screened out based on the FC value less than 0.02 in COVID-19. Green: Control subjects, blue: Influenza subjects, red: COVID-19 subjects

Back to article page